End to End Market Access Red Nucleus’s acquisitions create an integrated platform spanning market access, medical communications, and learning services, enabling a single partner for global launch, pricing strategy, payer evidence, and commercialization—a strong lead for cross-sell opportunities with pharma and biotech clients.

HEOR and Evidence The addition of Bridge Medical strengthens health economics and outcomes research capabilities, enabling you to propose value dossiers, payer analytics, budget impact models, and real world evidence programs to prospective clients.

Security and Compliance A cybersecurity incident highlights the critical need for data protection in life sciences; position cybersecurity, data governance, privacy, and regulatory compliance services to help clients safeguard trial data and commercial information.

Learning and Enablement Actando and Alpha Group integrations emphasize a strong base in learning and sales enablement; offer global, digital training and engaging content to accelerate market readiness and harmonize commercial skills across geographies.

Local Growth Hub Located in Cambridge, MA, you sit in a dense biotech corridor; target mid-market biotech and specialty pharma in need of nimble, high-touch market access and commercialization support with fast onboarding.